Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer-Reference-Cited by-同舟云学术

Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer

Published:2011-10-13 Issue:24 Volume:17 Page:7828-7834
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Bago-Horvath Zsuzsanna,Rudas Margaretha,Dubsky Peter,Jakesz Raimund,Singer Christian F.,Kemmerling Ralf,Greil Richard,Jelen Andrea,Böhm Gerhard,Jasarevic Zerina,Haid Anton,Gruber Christine,Pöstlberger Sabine,Filipits Martin,Gnant Michael

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study;Breast Cancer Research;2022-12-16

2. The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor–Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8;Clinical Cancer Research;2021-08-11

3. Assessment of 25-Year Survival of Women With Estrogen Receptor–Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy;JAMA Network Open;2021-06-30

4. Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the ABCSG Trial 5;Clinical Cancer Research;2020-06-16

5. Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens;Virchows Archiv;2020-05-07